Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modulation of Social Cognition via Hallucinogens and “Entactogens”
Katrin H. Preller, Franz X. Vollenweider
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study
B. Anderson, Alicia Danforth, Prof Robert Daroff, et al.
EClinicalMedicine (2020) Vol. 27, pp. 100538-100538
Open Access | Times Cited: 204
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 4, pp. 636-735
Open Access | Times Cited: 16
Supportive Touch in Psychedelic Assisted Therapy
Logan Neitzke‐Spruill, Caroline Beit, Lynnette A. Averill, et al.
The American Journal of Bioethics (2025) Vol. 25, Iss. 1, pp. 29-39
Closed Access | Times Cited: 5
Combining Psychedelic and Mindfulness Interventions: Synergies to Inform Clinical Practice
Jake Payne, Richard Chambers, Paul Liknaitzky
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 2, pp. 416-423
Open Access | Times Cited: 66
Classic Psychedelic Drugs: Update on Biological Mechanisms
Franz X. Vollenweider, John Smallridge
Pharmacopsychiatry (2022) Vol. 55, Iss. 03, pp. 121-138
Open Access | Times Cited: 64
Belief changes associated with psychedelic use
Sandeep M. Nayak, Manvir Singh, David B. Yaden, et al.
Journal of Psychopharmacology (2022) Vol. 37, Iss. 1, pp. 80-92
Open Access | Times Cited: 47
Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study
Natasha L. Mason, Attila Szabó, Kim P. C. Kuypers, et al.
Brain Behavior and Immunity (2023) Vol. 114, pp. 299-310
Open Access | Times Cited: 38
Classical Psychedelics as Therapeutics in Psychiatry – Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders
Lea J. Mertens, Katrin H. Preller
Pharmacopsychiatry (2021) Vol. 54, Iss. 04, pp. 176-190
Closed Access | Times Cited: 52
Psychedelics, Sociality, and Human Evolution
José Manuel Rodríguez Arce, Michael Winkelman
Frontiers in Psychology (2021) Vol. 12
Open Access | Times Cited: 49
A neurobiological perspective on social influence: Serotonin and social adaptation
Patricia Duerler, Franz X. Vollenweider, Katrin H. Preller
Journal of Neurochemistry (2022) Vol. 162, Iss. 1, pp. 60-79
Open Access | Times Cited: 28
Assessment of the Acute Effects of 2C‐B vs. Psilocybin on Subjective Experience, Mood, and Cognition
Pablo Mallaroni, Natasha L. Mason, Johannes T. Reckweg, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 114, Iss. 2, pp. 423-433
Open Access | Times Cited: 17
Mindfulness meditation and psychedelics: potential synergies and commonalities
Paweł Holas, Justyna Kamińska
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1398-1409
Open Access | Times Cited: 16
Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers
Juliana Mendes Rocha, Giordano Novak Rossi, Flávia de Lima Osório, et al.
Journal of Clinical Psychopharmacology (2021) Vol. 41, Iss. 3, pp. 267-274
Closed Access | Times Cited: 39
Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors
Polina Ponomarenko, Federico Seragnoli, Abigail E. Calder, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 660-678
Open Access | Times Cited: 15
Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective—a new and evolving approach
Phil Wolfson, Gita Vaid
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 5
Could Psychedelics be useful in the Treatment of Patients with Personality Disorder? A Case Report of Psychotherapy with Concomitant Use of Psychedelics
Martin Blay, Inès Benmakhlouf, Mario Speranza
Psychiatry Research Case Reports (2025), pp. 100245-100245
Open Access
Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper
Marianne Destoop, Pavel Mohr, Florence Butlen-Ducuing, et al.
European Psychiatry (2025) Vol. 68, Iss. 1
Open Access
Exploring the Role of Psychedelic Experiences on Wellbeing and Symptoms of Disordered Eating
Nadine Loh, David Luke
Psychoactives (2025) Vol. 4, Iss. 1, pp. 7-7
Open Access
Acute subjective effects of psychedelics in naturalistic group settings prospectively predict longitudinal improvements in trauma symptoms, trait shame, and connectedness among adults with childhood maltreatment histories
C. J. Healy, Aaron Frazier, Stephen Kirsch, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111361-111361
Open Access
Novel Psychoactive Phenethylamines: Impact on Genetic Material
Veronica Cocchi, Sofia Gasperini, Patrizia Hrelia, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9616-9616
Open Access | Times Cited: 31
Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics
Nicolas Langlitz, Erika Dyck, Milan Scheidegger, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 24
Social identity processes as a vehicle for therapeutic success in psychedelic treatment
Martha Newson, S. Alexander Haslam, Catherine Haslam, et al.
Nature Mental Health (2024) Vol. 2, Iss. 9, pp. 1010-1017
Closed Access | Times Cited: 3
Psychedelic Cognition—The Unreached Frontier of Psychedelic Science
Maria Bălăeţ
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 15
Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees
Maggie Kiraga, Kim P. C. Kuypers, Malin V. Uthaug, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 15
The relationship between the default mode network and the theory of mind network as revealed by psychedelics – A meta-analysis
Carla Soares, Gerardo Gonzalo, João Castelhano, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 152, pp. 105325-105325
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top